N4 PHARMA PLC — Major Shareholding Notification 2015

Oct 23, 2015

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 2558D

Evgen Pharma PLC

23 October 2015

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:			Evgen Pharma PLC
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights				x
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the notification obligation:		AXA Investment Managers S.A.
4. Full name of shareholder(s) (if different from 3.):
5. Date of the transaction and date on which the threshold is crossed or reached:		21 October 2015
6. Date on which issuer notified:		23 October 2015
7. Threshold(s) that is/are crossed or reached:		5.00 %

8. Notified details:
A: Voting rights attached to shares
Class/type of shares if possible using the ISIN CODE	Situation previous to the triggering transaction		Resulting situation after the triggering transaction
Number of Shares	Number of Voting Rights	Number of shares	Number of voting rights		% of  voting rights
Direct	Direct	Indirect	Direct	Indirect
GB00BSVYN304	0	0	0	0	6,485,000	0.00 %	8.90 %

B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument	Expiration date	Exercise/ Conversion Period	Number of voting rights that may be acquired if the instrument is exercised/ converted.	% of voting rights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument	Exercise price	Expiration date	Exercise/ Conversion period	Number of voting rights instrument refers to	% of voting rights
Nominal	Delta

Total (A+B+C)
Number of voting rights	Percentage of voting rights
6,485,000	8.90 %

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:
13. Additional information:	AXA Investment Managers S.A. crossed the 5% threshold following Evgen Pharma PLC initial public offering on the AIM market dated 21st October 2015
14. Contact name:	Pascaline HAYE
15. Contact telephone number:	+ 33 1 44 45 55 77 01

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLBGBDGCDDBGUX